RTW Investments’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,304,977
Closed -$25.7M 84
2022
Q4
$25.7M Buy
2,304,977
+260,665
+13% +$2.53M 0.53% 35
2022
Q3
$11.5M Sell
2,044,312
-14,192
-0.7% -$88.9K 0.26% 51
2022
Q2
$8.91M Hold
2,058,504
0.23% 65
2022
Q1
$24M Hold
2,058,504
0.5% 48
2021
Q4
$37.6M Buy
2,058,504
+197,295
+11% +$2.5M 0.55% 52
2021
Q3
$22.1M Hold
1,861,209
0.33% 59
2021
Q2
$32M Hold
1,861,209
0.48% 51
2021
Q1
$34M Sell
1,861,209
-64,385
-3% -$1.35M 0.53% 51
2020
Q4
$36.2M Buy
1,925,594
+1,701
+0.1% +$36.7K 0.61% 40
2020
Q3
$40.6M Buy
1,923,893
+14,533
+0.8% +$340K 0.98% 32
2020
Q2
$55.1M Buy
1,909,360
+939,882
+97% +$28.3M 1.55% 24
2020
Q1
$33.9M Buy
+969,478
New +$31.4M 1.46% 24

Other funds holding OYST

RTW Investments's OYST Position: Q1 2023 in Review

RTW Investments sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 2,304,977 shares — an estimated $25.7M sold.

RTW Investments first reported a position in OYST in Q1 2020 and held it in 12 quarters. The position peaked at $55.1M in Q2 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • RTW Investments reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • RTW Investments sold 2,304,977 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $25.7M.
  • RTW Investments first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2020 and held it in 12 quarters.
  • RTW Investments's Oyster Point Pharma, Inc. Common Stock position peaked at $55.1M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on RTW Investments's 13F filing for Q1 2023, filed 15 May 2023.